How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011

European Journal of Health Economics

Volumn 15, Issue 8, 2014, Pages 813-828

  Kiil, Astrid ^a   Houlberg, Kurt ^a  

^a KORA Danish Institute for Local and Regional Government Research   (Denmark)

Author keywords

Behavioural effects; Copayment; Demand effects; Distributional consequences; Health

Indexed keywords

EID: 84882740650     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-013-0526-8     Document Type: Article

References (71)

1. Rovira, J., et al.: Comparing cost-sharing in European Union member states: a system-oriented framework. In: Leidl, R. (ed.) Health Care and Its Financing in the Single European Market, pp. 183–211. IOS Press, Amsterdam (1998)
2. Hansen, S.W., Houlberg, K.: Brugerbetaling på sundheds- og ældreområdet i komparativt perspektiv. AKF, Copenhagen (2012)
3. Gibson, T.B., Ozminkowski, R.J., Goetzel, R.Z.: The effects of prescription drug cost sharing: a review of the evidence. Am. J. Manag. Care 11, 730–740 (2005)
4. Goldman, D.P., Joyce, G.F., Zheng, Y.: Prescription drug cost sharing. Associations with medication and medical utilization and spending and health. J. Am. Med. Assoc. 298(1), 61–69 (2007)
5. Gemmill, M.C., Thomson, S., Mossialos, E.: What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int. J. Equity Health 7(12), (2008)
6. Lexchin, J., Grootendorst, P.: Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int. J. Health Serv. 34(1), 101–122 (2004)
7. Carrieri, V.: The effects of cost-sharing in health care: what do we know from empirical evidence? Economia politica. J. Anal. Inst. Econ. 2, 351–374 (2010)
8. Holst, J.: Patient Cost Sharing—Reforms without Evidence, pp. 1–146. Social Science Research Centre, Berlin (2010)
9. Swartz, K.: Cost-sharing: effects on spending and outcomes. In: The Synthesis Project, pp. 1–36. Robert Wood Johnson Foundation (2010)
10. Rice, T., Matsuoka, K.Y.: The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors. Med. Care Res. Rev. 61(4), 415–452 (2004)
11. Manning, W.G., et al.: Health insurance and the demand for medical care: evidence from a randomized experiment. Am. Econ. Rev. 77, 251–277 (1987)
12. Lohr, K.N., et al.: Use of medical care in the RAND health insurance experiment. Med. Care 24(9 Suppl), S1–S87 (1986)
13. Shapiro, M.F., Ware, J.E., Sherbourne, C.D.: Effects of cost sharing on seeking care for serious and minor symptoms. Results of a randomized controlled trial. Ann. Intern. Med. 104(2), 246–251 (1986)
14. Siu, A.L., et al.: Inappropriate use of hospitals in a randomized trial of health insurance plans. N. Engl. J. Med. 315, 1259–1266 (1986)
15. Brook, R.H., et al.: Does free care improve adults’ health? Results from a randomized controlled trial. N. Engl. J. Med. 309(23), 1426–1434 (1983)
16. Robinson, R.: User charges for health care. In: Mossialos, E., et al. (eds.) Funding Health Care: Options for Europe, pp. 161–183. Open University Press, London (2002)
17. Arrow, K.J.: Uncertainty and the welfare economics of medical care. Am. Econ. Rev. 53, 941–973 (1963)
18. Pauly, M.V.: The economics of moral hazard: comment. Am. Econ. Rev. 58, 531–537 (1968)
19. The World Bank: Country and Lending Groups. 2012 [cited 2012 27/2]. Available from: http://data.worldbank.org/about/country-classifications/country-and-lending-groups#High_income
20. Atherly, A.: Medicare’s accidental stepchild. Med. Care Res. Rev. 2, 131–161 (2001)
21. Kiil, A.: Does employment-based private health insurance increase the use of covered health care services? A matching estimator approach. Int. J. Health Care Financ. Econ. 12(1), 1–38 (2012)
22. Almarsdóttir, A.B., Morgall, J.M., Grimsson, A.: Cost containment of pharmaceutical use in Iceland: the impact of liberalisation and user charges. J. Health Serv. Res. Policy 5(2), 109–113 (2000)
23. Atella, V., et al.: Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patients. Health Econ. 15, 875–892 (2006)
24. Augurzky, B., Bauer, T.K., Schaffner, S.: Copayments in the German Health System: Does It Work? in IZA Discussion Paper No. 2290 (2006)
25. Blais, L., et al.: Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance. Health Policy 64, 163–172 (2003)
26. Bolin, K., et al.: Utilisation of physician services in the 50+ population. The relative importance of individual versus institutional factors in 10 European countries. Int. J. Health Care Financ. Econ. 9(1), 83–112 (2009)
27. Cherkin, D.C., Grothaus, L., Wagner, E.H.: Is magnitude of co-payment effect related to income? Using census data for health services research. Soc. Sci. Med. 43(1), 33–41 (1992)
28. Christensen, B.: Characteristics of attenders and non-attenders at health examinations for ischaemic heart disease in general practice. Scand. J. Prim. Health Care 13, 26–31 (1995)
29. Christensen, B.: Payment and attendance at general practice preventive health examinations. Fam. Med. 27(8), 531–534 (1995)
30. Cockx, B., Brasseur, C.: The demand for physician services. Evidence from a natural experiment. J. Health Econ. 22, 881–913 (2003)
31. Contoyannis, P., et al.: Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec. Can. Health Econ. 14, 909–923 (2005)
32. Costa-Font, J., Kanavos, P., Rovira, J.: Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia. Appl. Econ. 39(5), 541–551 (2007)
33. Elofsson, S., Undén, A.-L., Krakau, I.: Patient charges—a hindrance to financially and psychologically disadvantage groups seeking care. Soc. Sci. Med. 46(10), 1375–1380 (1998)
34. Fiorio, C.V., Siciliani, L.: Co-payments and the demand for pharmaceuticals: evidence from Italy. Econ. Model. 27, 835–841 (2010)
35. Grootendorst, P., Levine, M.: Do Drug Plans Matter? Effects of Drug Plan Eligibility on Drug Use Among the Elderly, Social Assistance Recipients and the General Population, in QSEP Research Report No. 372. McMaster University (2002)
36. Gundgaard, J.: Income-related inequality in utilization of health services in Denmark: evidence from Funen County. Scand. J. Public Health 34, 10 (2006)
37. Jordin, B., Engholm, G.: Besöksfrekvenser för unga och äldre efter införandet av avgiftsfrihet för patienter yngre än 20 år. Socialmedicinsk tidsskrift: Organ för sjuk- och hälsovård 1, 85–90 (2001)
38. Kim, J.Y., Ko, S.K., Yang, B.M.: The effects of patient cost sharing on ambulatory utilization in South Korea. Health Policy 72(3), 293–300 (2005)
39. Kupor, S.A., et al.: The effect of copayments and income on the utilization of medical care by subscribers to Japan’s National Health Insurance System. Int. J. Health Serv. 25(2), 295–312 (1995)
40. Krutilová, V.: Impact of user fees in health care system on health care consumption. Rev. Econ. Perspect. 10(4), 113–132 (2010)
41. Layte, R., et al.: Do consultation charges deter general practitioner use among older people? Soc. Sci. Med. 68, 1432–1438 (2009)
42. Li, X., et al.: The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. Health Policy 82, 340–347 (2007)
43. Lostao, L., et al.: Patient cost sharing and social inequalities in access to health care in three western European countries. Soc. Sci. Med. 65, 367–376 (2007)
44. Lostao, L., et al.: Patient cost sharing and physician visits by socioeconomic position: findings in three Western European countries. J. Epidemiol. Community Health 61(5), 416–420 (2007)
45. Lundberg, L., et al.: Effects of user charges on the use of prescription medicines in different socio-economic groups. Health Policy 44, 123–134 (1998)
46. McManus, P., et al.: Prescription drug utilization following patient co-payment changes in Australia. Pharmacoepidemiol. Drug Saf. 5, 385–392 (1996)
47. Nexøe, J., Kragstrup, J., Rønne, T.: Impact of postal invitations and user fee on influenza vaccination rates among the elderly. Scand. J. Prim. Health Care 15, 109–112 (1997)
48. Nolan, A.: Evaluating the impact of eligibility for free care on the use of general practitioner (GP) services: a difference-in-difference matching approach. Soc. Sci. Med. 67, 1164–1172 (2008)
49. O’Reilly, D., et al.: Consultation charges in Ireland deter a large proportion of patients from seeing the GP: results of a cross-sectional survey. Eur. J. Gen. Pract. 13, 231–236 (2007)
50. Or, Z., Jusot, F., Yilmaz, E.: Impact of Health Care System on Socioeconomic Inequalities in Doctor Use, in IRDES Working Paper No. 17, Paris (2008)
51. Pilote, L., et al.: The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients. Can. Med. Assoc. J. 167(3), 246–252 (2002)
52. Poirier, S., et al.: The effect of a $2 co-payment on prescription refill rates of quebec elderly and its relationship to socio-economic status. Can. Pharm. J. 130(10), 30–34 (1998)
53. Puig-Junoy, J., García-Gómez, P., Casado-Marín, D.: Free Medicines Thanks to Retirement: Moral Hazard and Hospitalization Offsets in an NHS, in Tintenberg Institute Discussion Paper 108/3 (2011)
54. Rosen, B., et al.: When co-payments for physician visits can affect supply as well as demand: findings from a natural experiment in Israel’s national health insurance system. Int. J. Health Plan. Manag. 26, e68–e84 (2011)
55. Rückert, I.-M., Böcken, J., Mielck, A.: Are German patients burdened by the practice charge for physician visits (‘Praxisgebuehr’)? A cross sectional analysis of socio-economic and health related factors. BMC Health Serv. Res. 8(232), 2008
56. Schreyögg, J., Grabka, M.M.: Copayments for Ambulatory Care in Germany: A Natural Experiment Using a Difference-in-Difference Approach, in SOEP Papers on Multidisciplinary Panel Data Research. DIW, Berlin (2008)
57. Scott, K.M., Marwick, J.C., Crampton, P.R.: Utilization of general practitioner services in New Zealand and its relationship with income, ethnicity and government subsidy. Health Serv. Manag. Res. 16(1), 45–55 (2003)
58. Simonsen, M., Skipper, L., Skipper, N.: Price Sensitivity of Demand for Prescription Drugs: Exploiting a Regression Kink Design, in Economics Working Paper. School of Economics and Management, Aarhus University (2010)
59. Skipper, N.: On Utilization and Stockpiling of Prescription Drugs when Co-payments Increase: Heterogeneity Across Types of Drugs, in Economics Working Paper. School of Economics and Management, Aarhus University (2010)
60. Street, A., Jones, A., Furuta, A.: Cost-sharing and pharmaceutical utilisation and expenditure in Russia. J. Health Econ. 18, 459–472 (1999)
61. Tamblyn, R., et al.: Adverse events associated with prescription drug cost-sharing among poor and elderly persons. J. Am. Med. Assoc. 285(4), 421–429 (2001)
62. van de Voorde, C., van Doorslaer, E., Schokkaert, E.: Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demand. Health Econ. 10, 457–471 (2001)
63. van Doorslaer, E., et al.: The redistributive effect of health care finance in twelve OECD countries. J. Health Econ. 18, 291–313 (1999)
64. Wagstaff, A., et al.: Equity in the finance of health care: some further international comparisons. J. Health Econ. 18, 263–290 (1999)
65. Wang, P.S., et al.: Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants. J. Mental Health Policy Econ. 13(1), 37–44 (2010)
66. Winkelmann, R.: Co-payments for prescription drugs and the demand for doctor visits—evidence from a natural experiment. Health Econ. 13, 1081–1089 (2004)
67. Zápal, J.: Doctor-visit co-payment exemption for children: first look at the data. Czech J. Econ. Financ. 60(1), 58–72 (2010)
68. Zhong, H.: Equity in pharmaceutical utilization in Ontario: a cross-section and over time analysis. Can. Public Policy 33(4), 487–507 (2007)
69. Louckx, F.: Patient cost sharing and access to health care. In: Mackenbach, J., Bakker, M. (eds.) Reducing Inequalities in Health. A European Perspective, pp. 188–198. Routledge, London (2002)
70. Paulus, A., Sutherland, H., Tsakloglou, P.: The distributional impact of in-kind public benefits in European countries. J. Policy Anal. Manag. 29, 243–266 (2010)
71. Aaberge, R., et al.: The Distributional Impact of Public Services when Needs Differ, in IZA Discussion Paper No. 4826. Institute for the study of Labor, Bonn (2010)